The user facility reported to terumo cardiovascular that prior to cardiopulmonary bypass, during setup, a leak was notice during gas calibration.No patient involvement as this occurred during setup, product was changed out, procedure completed successfully.
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on july 24,2018.(b)(4).The returned sample was visually inspected.Buffer solution was present within the returned device, although it appeared to be less than the normal observed retention sample level.There were no other noted anomalies with the returned sample.The returned sample was then leak tested by connecting with the calibrated manometer, submerged into a water bath, and pressurized up to 1030 mmhg, and no leaks were noted.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|